Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Kochanek

Showing results (31-40 of 117) with videos related to

Pageof 12
Sort By:
Critical Care (London, England)|April 15, 2017
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their managementFrank Kroschinsky, Friedrich Stölzel, Simone von Bonin, et al.
Critical Care Medicine|May 19, 2025
Multicomponent Communication Intervention to Support Family Members of the Critically Ill: A Controlled Pre-Post StudyEyleen Reifarth, Boris Böll, Sascha Köpke, et al.
Journal of Intensive Care Medicine|November 18, 2021
Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill PatientsJan-Hendrik Naendrup, Jorge Garcia Borrega, Dennis Alexander Eichenauer, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|May 20, 2025
[Recommendation for medical onboarding and training on internal medicine intensive care units]Janika Briegel, Anna Carola Hertrich, Julian Hoffmann, et al.
Critical Care Medicine|April 11, 2012
Mild therapeutic hypothermia in cardiogenic shock syndromeCarsten Zobel, Christoph Adler, Anna Kranz, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 18, 2012
The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cellsAlexander Shimabukuro-Vornhagen, Andreas Draube, Tanja M Liebig, et al.
Hemasphere|November 15, 2019
In the Eye of the Storm: Immune-mediated Toxicities Associated With CAR-T Cell TherapyJorge Garcia Borrega, Philipp Gödel, Maria Adele Rüger, et al.
Deutsche Medizinische Wochenschrift (1946)|July 31, 2020
[COVID-19: The Intensive Care Point-of-View]Stephanie-Susanne Stecher, Hans Joachim Stemmler, Dennis Eichenauer, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|June 21, 2023
[Sustainability in intensive and emergency care : A nationwide survey by the German Society of Medical Intensive Care and Emergency Medicine]Jorge Garcia Borrega, Carsten Hermes, Victoria König, et al.
Clinical Kidney Journal|January 14, 2022
Plasma exchange with COVID-19 convalescent plasma in a patient with severe ANCA-associated vasculitis and COVID-19 pneumonia after rituximab therapyMatthias Kochanek, Jorge Garcia Borrega, Laura Beckmann, et al.
Pageof 12

Showing results (31-40 of 117) with videos related to

Sort By:
Pageof 12
Critical Care (London, England)|April 15, 2017
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their managementFrank Kroschinsky, Friedrich Stölzel, Simone von Bonin, et al.
Critical Care Medicine|May 19, 2025
Multicomponent Communication Intervention to Support Family Members of the Critically Ill: A Controlled Pre-Post StudyEyleen Reifarth, Boris Böll, Sascha Köpke, et al.
Journal of Intensive Care Medicine|November 18, 2021
Reactivation of EBV and CMV in Severe COVID-19-Epiphenomena or Trigger of Hyperinflammation in Need of Treatment? A Large Case Series of Critically ill PatientsJan-Hendrik Naendrup, Jorge Garcia Borrega, Dennis Alexander Eichenauer, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|May 20, 2025
[Recommendation for medical onboarding and training on internal medicine intensive care units]Janika Briegel, Anna Carola Hertrich, Julian Hoffmann, et al.
Critical Care Medicine|April 11, 2012
Mild therapeutic hypothermia in cardiogenic shock syndromeCarsten Zobel, Christoph Adler, Anna Kranz, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 18, 2012
The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cellsAlexander Shimabukuro-Vornhagen, Andreas Draube, Tanja M Liebig, et al.
Hemasphere|November 15, 2019
In the Eye of the Storm: Immune-mediated Toxicities Associated With CAR-T Cell TherapyJorge Garcia Borrega, Philipp Gödel, Maria Adele Rüger, et al.
Deutsche Medizinische Wochenschrift (1946)|July 31, 2020
[COVID-19: The Intensive Care Point-of-View]Stephanie-Susanne Stecher, Hans Joachim Stemmler, Dennis Eichenauer, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|June 21, 2023
[Sustainability in intensive and emergency care : A nationwide survey by the German Society of Medical Intensive Care and Emergency Medicine]Jorge Garcia Borrega, Carsten Hermes, Victoria König, et al.
Clinical Kidney Journal|January 14, 2022
Plasma exchange with COVID-19 convalescent plasma in a patient with severe ANCA-associated vasculitis and COVID-19 pneumonia after rituximab therapyMatthias Kochanek, Jorge Garcia Borrega, Laura Beckmann, et al.
Pageof 12